[Pathophysiology and clinical manifestations in pre-eclampsia].
BACKGROUND
Preeclampsia is a progressive, multisystem disorder characterised by hypertension and proteinuria. A body of evidence suggest a genetic basis; it is generally accepted that the underlying pathological processes are in the placenta.


METHODS
This article is a review of the pathophysiology of preeclampsia based on literature mainly obtained through PubMed and Medline searches.


RESULTS
A poorly perfused placenta, secondary to defective placental invasion of the spiral arteries, may lead to hypoxia and insufficient perfusion and cause release of cytokines which damage endothelial cells and cause dysfunction. Women with preeclampsia have markedly elevated concentrations of triglyceride-rich lipoproteins. Lipid peroxidation also causes endothelial dysfunction and thus contributes to preeclampsia. Placenta is one source of the lipid peroxides. Antioxidant deficiency is also a predisposing factor. Hyperhomocysteinaemia, protein S and protein C deficiency, and activated protein C resistance appear to be involved in the pathophysiology of severe preeclampsia and early onset preeclampsia.


CONCLUSIONS
The new information about mechanisms for development of preeclampsia gives a basis for new treatment modalities.
Haram
K
K
Kvinneklinikken, Haukeland Sykehus.
Bjørge
L
L
Guttu
K
K
D003656:Decidua / Q000098:blood supply / Q000473:pathology; D004730:Endothelium, Vascular / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D005260:Female; D006801:Humans; D007511:Ischemia; D010920:Placenta / Q000098:blood supply / Q000378:metabolism / Q000473:pathology; D011225:Pre-Eclampsia / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology / Q000503:physiopathology*; D011247:Pregnancy; D014327:Trophoblasts / Q000473:pathology
Patofysiologi og kliniske manifestasjoner ved preeklampsi.